Technical Development of Cardiovascular Magnetic Resonance Imaging
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Listed as NCT00027170, this observational or N/A phase trial focuses on Acute Myocardial Infarction and Cardiac Magnetic Resonance Imaging and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 36 times since 2001, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Study Description(click to expand)The purpose of this protocol is to allow development and testing of new MRI techniques suitable for evaluating patients with cardiovascular disease. Since such technical development work often depends on preliminary studies in healthy volunteers, the protocol also recruits healthy subjects. This protocol will provide the framework for technical development scans in patients with cardiovascular disease.
The purpose of this protocol is to allow development and testing of new MRI techniques suitable for evaluating patients with cardiovascular disease. Since such technical development work often depends on preliminary studies in healthy volunteers, the protocol also recruits healthy subjects. This protocol will provide the framework for technical development scans in patients with cardiovascular disease.
Status Flow
Change History
36 versions recorded-
Jan 2026 — Present [monthly]
Completed
-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Apr 2021 — Jul 2024 [monthly]
Completed
Phase: NA → None
-
Jan 2021 — Apr 2021 [monthly]
Completed NA
▶ Show 31 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Completed NA
Status: Suspended → Completed
-
Nov 2020 — Dec 2020 [monthly]
Suspended NA
-
Oct 2020 — Nov 2020 [monthly]
Suspended NA
-
Sep 2020 — Oct 2020 [monthly]
Suspended NA
-
Jul 2020 — Sep 2020 [monthly]
Suspended NA
-
Apr 2020 — Jul 2020 [monthly]
Suspended NA
-
Feb 2020 — Apr 2020 [monthly]
Suspended NA
-
Jan 2020 — Feb 2020 [monthly]
Suspended NA
-
Dec 2019 — Jan 2020 [monthly]
Suspended NA
-
Nov 2019 — Dec 2019 [monthly]
Suspended NA
Phase: None → NA
-
Oct 2019 — Nov 2019 [monthly]
Suspended
-
Sep 2019 — Oct 2019 [monthly]
Suspended
-
Jul 2019 — Sep 2019 [monthly]
Suspended
-
Jun 2019 — Jul 2019 [monthly]
Suspended
-
May 2019 — Jun 2019 [monthly]
Suspended
-
Apr 2019 — May 2019 [monthly]
Suspended
-
Mar 2019 — Apr 2019 [monthly]
Suspended
-
Feb 2019 — Mar 2019 [monthly]
Suspended
-
Jan 2019 — Feb 2019 [monthly]
Suspended
-
Dec 2018 — Jan 2019 [monthly]
Suspended
-
Nov 2018 — Dec 2018 [monthly]
Suspended
-
Oct 2018 — Nov 2018 [monthly]
Suspended
-
Sep 2018 — Oct 2018 [monthly]
Suspended
-
Aug 2018 — Sep 2018 [monthly]
Suspended
-
Jun 2018 — Aug 2018 [monthly]
Suspended
-
May 2018 — Jun 2018 [monthly]
Suspended
Status: Recruiting → Suspended
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jun 2017 — Aug 2017 [monthly]
Recruiting NA
-
May 2017 — Jun 2017 [monthly]
Recruiting NA
-
Jan 2017 — May 2017 [monthly]
Recruiting NA
First recorded
Nov 2001
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Heart, Lung, and Blood Institute (NHLBI)
For direct contact, visit the study record on ClinicalTrials.gov .